Synthesis and biological evaluation of 2,3-diaryl substituted-1,3 thiazolidin-4-ones as anti-HIV agents

Medicinal Chemistry

Volumn 3, Issue 4, 2007, Pages 355-363

  Rawal, Ravindra K ^a   Tripathi, Raj Kamal ^a   Katti, S B ^a   Pannecouque, Christophe ^b   De Clercq, Erik ^b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Anti HIV activity; Metathiazanones; NNRTIs; Thiazolidin 4 one

Indexed keywords

1 THIA AZA SPIRO[4,5]DECAN 3 ONE; 1,3 THIAZOLIDIN 4 ONE; 2 (2 CHLORO 6 FLUOROPHENYL) 3 (3 TRIFLUOROMETHYLPHENYL)THIAZOLIDIN 4 ONE; 2 (2 CHLORO 6 FLUOROPHENYL) 3 (5 METHYLFURAN 2 YLMETHYL)THIAZOLIDIN 4 ONE; 2 (2 CHLORO 6 FLUOROPHENYL) 3 FURAN 2 YLMETHYLTHIAZOLIDIN 4 ONE; 2 (2,6 DICHLOROPHENYL) 3 (3 TRIFLUOROMETHYLPHENYL)THIAZOLIDIN 4 ONE; 2 (2,6 DICHLOROPHENYL) 3 (5 METHYLFURAN 2YLMETHYL)THIAZOLIDIN 4 ONE; 2 (2,6 DICHLOROPHENYL) 3 FURAN 2 YLMETHYL[1,3]THIAZINAN 4 ONE; 2 (2,6 DICHLOROPHENYL) 3 FURAN 2 YLMETHYLTHIAZOLIDIN 4 ONE; 2 (2,6 DIFLUOROPHENYL) 3 (5 METHYLFURAN 2 YLMETHYL)THIAZOLIDIN 4 ONE; 2 (2,6 DIFLUOROPHENYL) 3 FURAN 2 YLMETHYL 5 METHYLTHIAZOLIDIN 4 ONE; 2 (2,6 DIFLUOROPHENYL) 3 FURAN 2 YLMETHYLTHIAZOLIDIN 4 ONE; 2 (2,6 DIFLUROPHENYL) 3 (3 TRIFLUOROMETHYLPHENYL)THIAZOLIDIN 4 ONE; 2 (4 DIMETHYLAMINO PHENYL) 3 PYRIDIN 2 YL THIAZOLIDIN 4 ONE; 2 (4 DIMETHYLAMINOPHENYL) 3 FURAN 2 YLMETHYLTHIAZOLIDIN 4 ONE; 3 (6 METHYLPYRIDIN 2 YL) 2 (2,4,6 TRIMETHOXYPHENYL)THIAZOLIDIN 4 ONE; 3 FURAN 2 YLMETHYL 2 (2 METHOXYPHENYL)[1,3]THIAZINAN 4 ONE; 3 FURAN 2 YLMETHYL 2 PYRIDIN 3 YLTHIAZOLIDIN 4 ONE; 3 FURAN 2 YLMETHYL 2 QUINOLIN 4 YLTHIAZOLIDIN 4 ONE; 3 PYRIDIN 2 YL 2 QUINOLIN 4 YLTHIAZOLIDIN 4 ONE; 4 FURAN 2YLMETHYL 1 THIA 4 AZA SPIRO[4,5]DECAN 3 ONE; 4 METATHIAZANONE; 4 THIAZOLIDINEDIONE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; BENZIMIDAZOLE DERIVATIVE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG SCREENING; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTI-HIV AGENTS; CELL LINE; HIV-1; HIV-2; HUMANS; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLIDINES;

EID: 34447569299     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340607781024393     Document Type: Article

References (17)

1. Jonckheere, H.; Anne, J.; De Clercq, E. Med. Res. Rev., 2000, 20, 129.
2. De Clercq, E. J. Med. Chem., 2005, 10, 1297.
3. Garg, R.; Gupta, S.P.; Gao, H.; Babu; M.S.; Debnath, AK; Hansch, C. Chem. Rev., 1999, 99, 3525.
4. Schafer, W.; Friebe, W.G.; Leinert, M.; Merttens, A.; Poll, T.; Von der Saal, W.; Zilch, H.; Nuber, H.; Ziegler, M.L. J. Med. Chem., 1993, 36, 726.
5. Barreca, M.L.; Balzarini, J.; Chimirri, A.; De Clercq, E.; Luca, L.D.; Holtje, M.H.; Holtje, M.; Monforte, A.M.; Monforte, P.; Pannecouque, C.; Rao, A.; Zappala, M. J. Med. Chem., 2002, 45, 5410.
6. Rao, A.; Balzarini, J.; Carbone, A.; Chimirri, A.; De Clercq, E.; Monforte, A.M.; Monforte, P.; Pannecouque, C.; Zappala, M. Antiviral Res., 2004, 63, 79.
7. Rao, A.; Balzarini, J.; Carbone, A.; Chimirri, A.; De Clercq, E.; Monforte, A.M.; Monforte, P.; Pannecouque, C.; Zappala, M. IL Formaco, 2004, 59, 33.
8. Barreca, M.L.; Balzarini, J.; Chimirri, A.; Luca, L.D.; Monforte, A.M.; Monforte, P.; Rao, A.; Zappala, M.; Balzarini, J.; De Clercq, E.; Pannecouque, C.; Witvrouv, M. Bioorg. Med. Chem. Lett., 2001, 11, 1793.
9. Rawal, R.K.; Solomon, V.Raja; Prabhakar, Y.S.; Katti, S.B.; De Clercq, E. Comb. Chem. High Throughput Screen., 2005, 8, 439.
10. Rawal, R.K.; Prabhakar, Y.S.; Katti, S.B.; De Clercq, E. Bioorg. Med. Chem., 2005, 13, 6771.
11. Prabhakar, Y.S.; Rawal, R.K.; Gupta, M.K.; Solomon, V.Raja; Katti, S.B. Comb. Chem. High Throughput Screen., 2005, 8, 431.
12. Prabhakar, Y.S.; Solomon, V.Raja; Rawal, R.K.; Gupta, M.K.; Katti, S.B. QSAR Comb. Sci., 2004, 23, 234.
13. Srivastava, T.; Haq, W.; Katti, S.B. Tetrahedron, 2002, 58, 7619.
14. Rawal, R.K.; Srivastava, T.; Haq, W.; Katti, S.B. J. Chem. Res., 2004, 368.
15. Holmes, C. P.; Chinn, J. P. Look, C. G. Gordon, E.M.; Gallop, M. A. J. Org. Chem. 1995, 60, 7328.
16. Reverse Transcriptase Assay, Colorimetric kit, Roche Diagnostics GmbH, Roche Applied Science, Sandhofer Strasses 116, D-68305 Mannheim, Germany.
17. Pauwels, R.; Balzarini, J.; Baba, M.; Snoeck, R.; Schols, D.; Herdewijin, P:; Desmyter, J.; De Clercq, E. J. Virol. Methods, 1988, 20, 309.